Alnylam Pharmaceuticals, Inc. (BMV:ALNY)

Alnylam Pharmaceuticals Statistics

Total Valuation

BMV:ALNY has a market cap or net worth of MXN 1.12 trillion. The enterprise value is 1.12 trillion.

Market Cap	1.12T
Enterprise Value	1.12T

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	131.08M
Shares Outstanding	n/a
Shares Change (YoY)	+4.82%
Shares Change (QoQ)	+5.14%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	98.03%
Float	126.87M

Valuation Ratios

The trailing PE ratio is 1,399.48 and the forward PE ratio is 49.52.

PE Ratio	1,399.48
Forward PE	49.52
PS Ratio	18.99
PB Ratio	260.67
P/TBV Ratio	260.67
P/FCF Ratio	275.42
P/OCF Ratio	229.32
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 156.18, with an EV/FCF ratio of 275.64.

EV / Earnings	1,400.61
EV / Sales	18.78
EV / EBITDA	156.18
EV / EBIT	227.80
EV / FCF	275.64

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 11.86.

Current Ratio	2.54
Quick Ratio	2.37
Debt / Equity	11.86
Debt / EBITDA	7.18
Debt / FCF	12.53
Interest Coverage	1.63

Financial Efficiency

Return on equity (ROE) is 32.73% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	32.73%
Return on Assets (ROA)	3.65%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.03%
Revenue Per Employee	26.40M
Profits Per Employee	358,331
Employee Count	2,230
Asset Turnover	0.71
Inventory Turnover	6.83

Taxes

Income Tax	-1.38B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+66.60%
50-Day Moving Average	3,821.82
200-Day Moving Average	n/a
Relative Strength Index (RSI)	76.36
Average Volume (20 Days)	344

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.45

Income Statement

In the last 12 months, BMV:ALNY had revenue of MXN 58.88 billion and earned 799.08 million in profits. Earnings per share was 6.05.

Revenue	58.88B
Gross Profit	49.40B
Operating Income	4.86B
Pretax Income	-585.90M
Net Income	799.08M
EBITDA	5.89B
EBIT	4.86B
Earnings Per Share (EPS)	6.05

Balance Sheet

The company has 49.98 billion in cash and 50.87 billion in debt, giving a net cash position of -892.99 million.

Cash & Cash Equivalents	49.98B
Total Debt	50.87B
Net Cash	-892.99M
Net Cash Per Share	n/a
Equity (Book Value)	4.29B
Book Value Per Share	32.55
Working Capital	43.97B

Cash Flow

In the last 12 months, operating cash flow was 4.88 billion and capital expenditures -816.21 million, giving a free cash flow of 4.06 billion.

Operating Cash Flow	4.88B
Capital Expenditures	-816.21M
Free Cash Flow	4.06B
FCF Per Share	n/a

Margins

Gross margin is 83.90%, with operating and profit margins of 8.25% and 1.36%.

Gross Margin	83.90%
Operating Margin	8.25%
Pretax Margin	-1.00%
Profit Margin	1.36%
EBITDA Margin	10.00%
EBIT Margin	8.25%
FCF Margin	6.90%

Dividends & Yields

BMV:ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.82%
Shareholder Yield	-4.82%
Earnings Yield	0.07%
FCF Yield	0.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:ALNY has an Altman Z-Score of 4.46 and a Piotroski F-Score of 5.

Altman Z-Score	4.46
Piotroski F-Score	5